Deep brain stimulation
This article was originally published in The Gray Sheet
Executive Summary
Deep brain stimulation is "a treatment option" for patients suffering from Parkinson's disease with motor complications, new guidelines from the American Academy of Neurology suggest. The April 3 release of the guidelines was welcome news to Medtronic, which manufactures Activa, one of the deep brain stimulators on the market used to treat that condition. The firm is seeking to broaden the use of Activa to treat obsessive-compulsive disorder and depression (1"The Gray Sheet" April 4, 2005, p. 16)...